Apogee Therapeutics, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APGE and other ETFs, options, and stocks.

About APGE

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. 

CEO
Michael Henderson
CEOMichael Henderson
Employees
196
Employees196
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2022
Founded2022
Employees
196
Employees196

APGE Key Statistics

Market cap
2.24B
Market cap2.24B
Price-Earnings ratio
-10.30
Price-Earnings ratio-10.30
Dividend yield
Dividend yield
Average volume
606.37K
Average volume606.37K
High today
$38.06
High today$38.06
Low today
$35.60
Low today$35.60
Open price
$36.18
Open price$36.18
Volume
1.10M
Volume1.10M
52 Week high
$63.50
52 Week high$63.50
52 Week low
$26.20
52 Week low$26.20

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own APGE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.